Understanding HCH

A clearer overview of hypochondroplasia, a type of FGFR3-related skeletal dysplasias, including its genetics, diagnosis, growth, variability, and how this genetic condition may affect individuals differently over time.

Hypochondroplasia is a lifelong genetic condition that impacts bone growth. It falls under the category of FGFR3-related skeletal dysplasias, which influence the development of both cartilage and bone. As a result of the affected bone growth, individuals with hypochondroplasia often have a shorter stature and may possess shorter arms and legs in relation to their body. Typical characteristics of hypochondroplasia include shorter height, shorter limbs in proportion to the body, and variations in growth and body proportions over time. These features can sometimes be subtle in early childhood, which is one reason why diagnosis isn't always immediate. Considered a rare genetic condition, hypochondroplasia is estimated to affect between approximately 1 in 15,000 and 1 in 40,000 people. Due to the challenges in diagnosis, the true prevalence of this condition may not be fully understood. For a detailed clinical overview, refer to the GeneReviews article on hypochondroplasia: https://www.ncbi.nlm.nih.gov/books/NBK1477/

Hypochondroplasia is a genetic condition caused by a change in the FGFR3 gene (fibroblast growth factor receptor 3). The FGFR3 gene is crucial for regulating and controlling bone growth. When this gene is altered, bone growth is slowed, particularly affecting the long bones. In most instances, the genetic change occurs for the first time in the child (de novo), and there is no family history of FGFR3-related skeletal dysplasias. However, in some families, hypochondroplasia can be inherited from a parent. This condition follows an autosomal dominant inheritance pattern, meaning a parent with hypochondroplasia has a 50% chance of passing the condition on to each child.

Diagnosis is usually based on a combination of: clinical features such as growth patterns and body proportions, imaging techniques including skeletal surveys or X-rays, and genetic testing for FGFR3-related skeletal dysplasias. However, diagnosing these genetic conditions is not always straightforward. Currently, there are no single standard diagnostic criteria, and features can overlap with familial short stature, unexplained or idiopathic short stature, other skeletal dysplasias, and various causes of short stature. Research suggests that diagnosis often depends on how features emerge and change over time. Pathways to facilitate early recognition and diagnosis of hypochondroplasia are essential for effective management.

Many families experience a delay between their first concerns and the eventual diagnosis of conditions like hypochondroplasia, which is one of the FGFR3-related skeletal dysplasias. This delay can occur for several reasons: early signs of hypochondroplasia may be subtle, growth differences might not be obvious at first, and some healthcare professionals may have limited familiarity with this genetic condition. Additionally, the features of hypochondroplasia can become clearer gradually over time.

Due to its subtlety and variability, hypochondroplasia is sometimes missed or mistaken for other causes of short stature or growth differences. Initially, some children may be described as having familial short stature, unexplained or idiopathic short stature, or developmental differences without a clear cause. 

For many families, understanding the nuances of hypochondroplasia and its classification among FGFR3-related skeletal dysplasias can help make sense of the diagnostic journey they experienced.

One of the most important things to understand about hypochondroplasia, a form of FGFR3-related skeletal dysplasias, is that it can vary significantly from one person to another. Some individuals with this genetic condition exhibit mild physical differences and have few medical concerns, while others may require monitoring, therapies, or additional support in several areas. Notably, some features may only become more pronounced over time.

Although hypochondroplasia is primarily known as a condition affecting bone growth, the FGFR3 gene is active in other parts of the body as well. This may help explain why some individuals experience developmental, neurological, hearing, sleep, or other health-related differences, while others do not.

This variability is well documented in GeneReviews and is one of the reasons it can be challenging to predict early on exactly how the hypochondroplasia will affect an individual child.

Children with hypochondroplasia, a type of FGFR3-related skeletal dysplasia, grow differently from their peers. They may move away from standard growth centiles over time and often show increasing disproportion as they grow. Head size in these children may also appear larger relative to height, even when head circumference measurements fall within standard ranges. This relationship has been studied using the Head Circumference Height Index (HCH-I), which helps identify relative differences between head size and height: https://pubmed.ncbi.nlm.nih.gov/41040055/. 

Standard growth charts do not accurately reflect the growth patterns of children with hypochondroplasia, a genetic condition that affects body proportions. Recent research has led to the development of growth reference charts specifically for children with hypochondroplasia, which may help healthcare professionals monitor growth more accurately over time: https://pubmed.ncbi.nlm.nih.gov/37814549/. 

Adult height can vary considerably among individuals with this condition. Historically reported adult height ranges are approximately: 

- Men: 138 to 165 cm (4 ft 6 in to 5 ft 5 in) 

- Women: 128 to 151 cm (4 ft 2 in to 4 ft 11 in). 

However, height is only one aspect of hypochondroplasia. Individual experiences, body proportions, health concerns, functional abilities, and day-to-day challenges can vary significantly from person to person.

Hypochondroplasia and achondroplasia are part of the same spectrum of FGFR3-related skeletal dysplasias. They share some features, but there are important differences. Compared with achondroplasia, hypochondroplasia is often milder in physical presentation, with features that are usually more subtle. Some complications associated with achondroplasia may be less common in this genetic condition. However, 'milder' does not mean without impact. Some individuals with hypochondroplasia may experience orthopaedic concerns such as bowed legs, changes in spinal alignment (including lumbar lordosis), back pain, or, less commonly, spinal stenosis. They may also face hearing issues, developmental differences, learning and/or intellectual challenges, sleep-related concerns, neurological symptoms like seizures and/or brain anomalies, and challenges related to pain, mobility, or fatigue. Every individual's experience with this genetic condition is different.

Research into hypochondroplasia, a type of FGFR3-related skeletal dysplasia, continues to develop. We now understand the genetic cause (FGFR3), many of the clinical and developmental features, and that this genetic condition is highly variable. However, there are still important gaps in early diagnosis, standardized care pathways, awareness and recognition among healthcare professionals, long-term outcomes, and quality-of-life research. This highlights the importance of ongoing research, education, and patient advocacy, which remain at the heart of our mission.

Findings from the qualitative study Living with Hypochondroplasia: Children’s and Caregivers’ Experiences, Challenges, and Unmet Needs have greatly improved our understanding of the lived experiences, challenges, and unmet needs of individuals and families affected by hypochondroplasia: https://www.endocrine-abstracts.org/ea/0099/ea0099p83

Our Parent Handbook brings together: medical information, practical guidance, and lived experiences from families dealing with FGFR3-related skeletal dysplasias, particularly hypochondroplasia. It also includes questions to ask healthcare professionals and information about everyday life with this genetic condition. Many families find it helpful to revisit the handbook over time as new questions arise and their understanding of hypochondroplasia develops.

Understanding hypochondroplasia, a type of FGFR3-related skeletal dysplasia, is not about learning everything at once. For most families, knowledge about this genetic condition develops gradually through: lived experience, conversations with healthcare professionals, connecting with other families, and learning what is and is not relevant to their child. Over time, many families become more confident in understanding: what matters most for their child, what may need monitoring, when to seek additional support, and how to navigate everyday life with greater confidence.